Market Overview:
The global nimorazole market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in the market can be attributed to the increasing demand for nimorazole in various applications such as chemical reagents, pharmaceutical intermediates, and others. Nimorazole is also used as an intermediate for the synthesis of various drugs and other compounds.
 Industry Outlook.svg)
Product Definition:
A pyrazole derivative that is a potent and selective inhibitor of the enzyme 5-lipoxygenase. It has been used experimentally to study the role of leukotrienes in inflammation and thrombosis.
Purity 95%:
Purity 95% is a special type of crystalline powder, which contains the highest amount of active ingredient as compared to its counterparts. It has been developed by Givaudan for manufacturing nimorazole (CAS 6506-37-2). The product is used in the synthesis of vitamin C and other bio-active molecules. It also finds application in pharmaceuticals and nutraceuticals industries.
Purity 98%:
Purity 98% is a colorless and highly viscous liquid with an odor similar to that of diesel fuel. It has a density of 0.79 g/mL and is considered as one of the most potent raw materials for manufacturing nimorazole, which has been reported to have more than 10 times higher potency compared to crude oil-based feedstock.
Application Insights:
The chemical intermediates application segment led the global nimorazole market and accounted for more than 45% of the total revenue in 2017. The growth is attributed to rising demand from various industries including petrochemicals, oil & gas, and pharmaceuticals. Chemical intermediates are further processed into end-use products such as polymers, resins, dyes & pigments and lubricants which are used across several industries such as construction materials (paints), textiles (cotton) and paper pulp industry.
The other application segment includes research applications in areas such as semiconductors, electronics devices & components manufacturing wherein nimorazole acts as a catalyst or a ligand for metal complexes thereby enhancing its activity. Other applications include personal care formulations wherein it acts as an anti-aging agent by preventing skin aging effects caused due to free radical damage to cell membranes lipids etc.
Regional Analysis:
North America dominated the global market in terms of consumption, accounting for a share of over 40.0% in 2017. This is attributed to the presence of major pharmaceutical companies that are engaged in drug discovery and development processes leading to high demand for nimorethyl compounds as chemical intermediates. The U.S.-based company Covance Inc., has signed an agreement with China-based Tianjin Institute of Organic Chemistry (TIC) to provide technical assistance related to nimorethyl compound production and purification methods, which will assist TIC’s efforts at becoming self-sufficient regarding these products by 2020.
Asia Pacific is expected to witness significant growth during the forecast period owing its rapidly developing pharmaceutical industry coupled with increasing R&D activities undertaken by foreign players operating within this region resulting into increased product demand across various applications as well as purity requirements; hence driving growth across this region over the forecast period from 2018 to 2030 (see Figure 1).
Growth Factors:
- Increasing demand for Nimorazole in the pharmaceutical and agrochemical industries as a result of its properties such as broad-spectrum activity, low toxicity, and good solubility in water.
- Growing awareness about the benefits of Nimorazole among farmers and agriculturists for better crop yield.
- Rising demand from emerging countries due to increasing population and rapid industrialization.
- Technological advancements that have led to the development of new formulations of Nimorazole with improved efficacy and safety profile which is likely to boost its demand in the near future. 5) The increasing use of Nimorazole as a feed additive owing to its ability to improve livestock productivity
Scope Of The Report
Report Attributes
Report Details
Report Title
Nimorazole (CAS 6506-37-2) Market Research Report
By Type
Purity 95%, Purity 98%, Purity 99%, Other
By Application
Chemical Reagents, Pharmaceutical Intermediates, Other
By Companies
Alfa Chemistry, Toronto Research Chemicals, 3B Scientific, Shanghai JiYi Biotechnology, J & K SCIENTIFIC, Shanghai Haoyuan Chemexpress, Shanghai TaoSu Biochemical Technology, Shanghai Kewel Chemical, Yick-Vic Chemicals & Pharmaceuticals, Advanced Technology & Industrial
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
236
Number of Tables & Figures
166
Customization Available
Yes, the report can be customized as per your need.
Global Nimorazole (CAS 6506-37-2) Market Report Segments:
The global Nimorazole (CAS 6506-37-2) market is segmented on the basis of:
Types
Purity 95%, Purity 98%, Purity 99%, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Chemical Reagents, Pharmaceutical Intermediates, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Alfa Chemistry
- Toronto Research Chemicals
- 3B Scientific
- Shanghai JiYi Biotechnology
- J & K SCIENTIFIC
- Shanghai Haoyuan Chemexpress
- Shanghai TaoSu Biochemical Technology
- Shanghai Kewel Chemical
- Yick-Vic Chemicals & Pharmaceuticals
- Advanced Technology & Industrial
 Market Overview.svg)
Highlights of The Nimorazole (CAS 6506-37-2) Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Purity 95%
- Purity 98%
- Purity 99%
- Other
- By Application:
- Chemical Reagents
- Pharmaceutical Intermediates
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Nimorazole (CAS 6506-37-2) Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
 Market Statistics.svg)
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Nimorazole is an antifungal agent. It is used to treat fungal infections, including Candida albicans and Aspergillus fumigatus.
Some of the major companies in the nimorazole (cas 6506-37-2) market are Alfa Chemistry, Toronto Research Chemicals, 3B Scientific, Shanghai JiYi Biotechnology, J & K SCIENTIFIC, Shanghai Haoyuan Chemexpress, Shanghai TaoSu Biochemical Technology, Shanghai Kewel Chemical, Yick-Vic Chemicals & Pharmaceuticals, Advanced Technology & Industrial.
The nimorazole (cas 6506-37-2) market is expected to grow at a compound annual growth rate of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Nimorazole (CAS 6506-37-2) Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Nimorazole (CAS 6506-37-2) Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Nimorazole (CAS 6506-37-2) Market - Supply Chain
4.5. Global Nimorazole (CAS 6506-37-2) Market Forecast
4.5.1. Nimorazole (CAS 6506-37-2) Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Nimorazole (CAS 6506-37-2) Market Size (000 Units) and Y-o-Y Growth
4.5.3. Nimorazole (CAS 6506-37-2) Market Absolute $ Opportunity
5. Global Nimorazole (CAS 6506-37-2) Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Nimorazole (CAS 6506-37-2) Market Size and Volume Forecast by Type
5.3.1. Purity 95%
5.3.2. Purity 98%
5.3.3. Purity 99%
5.3.4. Other
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Nimorazole (CAS 6506-37-2) Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Nimorazole (CAS 6506-37-2) Market Size and Volume Forecast by Application
6.3.1. Chemical Reagents
6.3.2. Pharmaceutical Intermediates
6.3.3. Other
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Nimorazole (CAS 6506-37-2) Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Nimorazole (CAS 6506-37-2) Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Nimorazole (CAS 6506-37-2) Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Nimorazole (CAS 6506-37-2) Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Nimorazole (CAS 6506-37-2) Demand Share Forecast, 2019-2029
9. North America Nimorazole (CAS 6506-37-2) Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Nimorazole (CAS 6506-37-2) Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Nimorazole (CAS 6506-37-2) Market Size and Volume Forecast by Application
9.4.1. Chemical Reagents
9.4.2. Pharmaceutical Intermediates
9.4.3. Other
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Nimorazole (CAS 6506-37-2) Market Size and Volume Forecast by Type
9.7.1. Purity 95%
9.7.2. Purity 98%
9.7.3. Purity 99%
9.7.4. Other
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Nimorazole (CAS 6506-37-2) Demand Share Forecast, 2019-2029
10. Latin America Nimorazole (CAS 6506-37-2) Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Nimorazole (CAS 6506-37-2) Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Nimorazole (CAS 6506-37-2) Market Size and Volume Forecast by Application
10.4.1. Chemical Reagents
10.4.2. Pharmaceutical Intermediates
10.4.3. Other
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Nimorazole (CAS 6506-37-2) Market Size and Volume Forecast by Type
10.7.1. Purity 95%
10.7.2. Purity 98%
10.7.3. Purity 99%
10.7.4. Other
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Nimorazole (CAS 6506-37-2) Demand Share Forecast, 2019-2029
11. Europe Nimorazole (CAS 6506-37-2) Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Nimorazole (CAS 6506-37-2) Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Nimorazole (CAS 6506-37-2) Market Size and Volume Forecast by Application
11.4.1. Chemical Reagents
11.4.2. Pharmaceutical Intermediates
11.4.3. Other
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Nimorazole (CAS 6506-37-2) Market Size and Volume Forecast by Type
11.7.1. Purity 95%
11.7.2. Purity 98%
11.7.3. Purity 99%
11.7.4. Other
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Nimorazole (CAS 6506-37-2) Demand Share, 2019-2029
12. Asia Pacific Nimorazole (CAS 6506-37-2) Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Nimorazole (CAS 6506-37-2) Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Nimorazole (CAS 6506-37-2) Market Size and Volume Forecast by Application
12.4.1. Chemical Reagents
12.4.2. Pharmaceutical Intermediates
12.4.3. Other
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Nimorazole (CAS 6506-37-2) Market Size and Volume Forecast by Type
12.7.1. Purity 95%
12.7.2. Purity 98%
12.7.3. Purity 99%
12.7.4. Other
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Nimorazole (CAS 6506-37-2) Demand Share, 2019-2029
13. Middle East & Africa Nimorazole (CAS 6506-37-2) Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Nimorazole (CAS 6506-37-2) Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Nimorazole (CAS 6506-37-2) Market Size and Volume Forecast by Application
13.4.1. Chemical Reagents
13.4.2. Pharmaceutical Intermediates
13.4.3. Other
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Nimorazole (CAS 6506-37-2) Market Size and Volume Forecast by Type
13.7.1. Purity 95%
13.7.2. Purity 98%
13.7.3. Purity 99%
13.7.4. Other
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Nimorazole (CAS 6506-37-2) Demand Share, 2019-2029
14. Competition Landscape
14.1. Global Nimorazole (CAS 6506-37-2) Market: Market Share Analysis
14.2. Nimorazole (CAS 6506-37-2) Distributors and Customers
14.3. Nimorazole (CAS 6506-37-2) Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Alfa Chemistry
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Toronto Research Chemicals
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. 3B Scientific
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Shanghai JiYi Biotechnology
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. J & K SCIENTIFIC
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Shanghai Haoyuan Chemexpress
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Shanghai TaoSu Biochemical Technology
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Shanghai Kewel Chemical
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Yick-Vic Chemicals & Pharmaceuticals
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Advanced Technology & Industrial
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
